SEC13
Gene Information
- Official Symbol: SEC13
- Official Name: SEC13 homolog, nuclear pore and COPII coat complex component
- Aliases and Previous Symbols: N/A
- Entrez ID: 6396
- UniProt: P55735
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Functions as a component of the nuclear pore complex (NPC) and the COPII coat. At the endoplasmic reticulum, SEC13 is involved in the biogenesis of COPII-coated vesicles. {ECO:0000269|PubMed:8972206}.
Pfam Domains GO Terms
Pfam Domains
| WD40 |
GO Terms
| nuclear pore outer ring |
| COPII-coated vesicle cargo loading |
| GATOR2 complex |
| COPII vesicle coat |
| positive regulation of TORC1 signaling |
| protein exit from endoplasmic reticulum |
| vesicle cargo loading |
| tRNA export from nucleus |
| tRNA-containing ribonucleoprotein complex export from nucleus |
| tRNA transport |
| ncRNA export from nucleus |
| regulation of TORC1 signaling |
| positive regulation of TOR signaling |
| ER to Golgi transport vesicle membrane |
| intracellular transport of virus |
| host cell |
| transport of virus |
| vesicle targeting, rough ER to cis-Golgi |
| COPII vesicle coating |
| vesicle coating |
| COPII-coated vesicle budding |
| vesicle targeting, to, from or within Golgi |
| multi-organism localization |
| multi-organism transport |
| Golgi vesicle budding |
| regulation of glycolytic process |
| regulation of cellular response to heat |
| localization within membrane |
| kinetochore |
| regulation of gene silencing by miRNA |
| regulation of carbohydrate catabolic process |
| vesicle targeting |
| regulation of gene silencing by RNA |
| regulation of posttranscriptional gene silencing |
| vesicle budding from membrane |
| antigen processing and presentation of peptide antigen via MHC class I |
| antigen processing and presentation of exogenous peptide antigen via MHC class II |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| antigen processing and presentation of peptide antigen via MHC class II |
| regulation of TOR signaling |
| mRNA-containing ribonucleoprotein complex export from nucleus |
| mRNA export from nucleus |
| viral transcription |
| regulation of purine nucleotide metabolic process |
| regulation of nucleotide metabolic process |
| regulation of ATP metabolic process |
| ribonucleoprotein complex export from nucleus |
| ribonucleoprotein complex localization |
| RNA export from nucleus |
| regulation of gene silencing |
| viral gene expression |
| protein export from nucleus |
| mRNA transport |
| nuclear export |
| regulation of generation of precursor metabolites and energy |
| establishment of vesicle localization |
| antigen processing and presentation of exogenous peptide antigen |
| nuclear envelope |
| antigen processing and presentation of exogenous antigen |
| vesicle localization |
| antigen processing and presentation of peptide antigen |
| RNA transport |
| structural molecule activity |
| nucleic acid transport |
| establishment of RNA localization |
| viral life cycle |
| regulation of carbohydrate metabolic process |
| endoplasmic reticulum to Golgi vesicle-mediated transport |
| RNA localization |
| antigen processing and presentation |
| nucleobase-containing compound transport |
| protein-containing complex localization |
| nucleocytoplasmic transport |
| nuclear transport |
| vesicle organization |
| lysosomal membrane |
| establishment of organelle localization |
| Golgi vesicle transport |
| regulation of small molecule metabolic process |
| organelle localization |
| Golgi membrane |
| intracellular membrane-bounded organelle |
| viral process |
| regulation of cellular response to stress |
| symbiotic process |
| interspecies interaction between organisms |
| membrane organization |
| endoplasmic reticulum membrane |
| regulation of catabolic process |
| intracellular protein transport |
| positive regulation of intracellular signal transduction |
| identical protein binding |
| regulation of response to stress |
| protein transport |
| intracellular transport |
| peptide transport |
| protein-containing complex assembly |
| amide transport |
| cellular protein localization |
| regulation of phosphorylation |
| cellular macromolecule localization |
| establishment of protein localization |
| positive regulation of signal transduction |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| establishment of localization in cell |
| nitrogen compound transport |
| protein-containing complex subunit organization |
| vesicle-mediated transport |
| gene expression |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| DTL | 0.567 |
| TBC1D3C | 0.539 |
| TBC1D3G | 0.536 |
| ATP6V1C1 | 0.525 |
| PSMB4 | 0.522 |
| TBC1D3H | 0.522 |
| SSH2 | 0.513 |
| NPIPB5 | 0.508 |
| ZNF106 | 0.501 |
| NUP160 | 0.498 |
| COPG1 | 0.495 |
| RBBP5 | 0.491 |
| NUPL1 | 0.489 |
| ANKLE2 | 0.489 |
| RPS2 | 0.488 |
| C1QTNF9B | 0.482 |
| RAD51 | 0.482 |
| DDTL | 0.482 |
| CHD4 | 0.477 |
| TCEB3C | 0.477 |
| HIST2H3A | 0.476 |
| HIST2H3C | 0.476 |
| TCEB3CL | 0.475 |
| C14orf93 | 0.475 |
| DOCK6 | 0.474 |
| TBC1D3F | 0.474 |
| TCEB3CL2 | 0.474 |
| CBWD5 | 0.471 |
| SNRPA1 | 0.468 |
| CBWD3 | 0.468 |
| SLC6A17 | 0.468 |
| CCNA2 | 0.468 |
| POLR2J3 | 0.467 |
| ORC6 | 0.465 |
| MED17 | 0.464 |
| TBC1D3I | 0.463 |
| HAP1 | 0.463 |
| TBC1D3L | 0.463 |
| TBC1D3K | 0.463 |
| TBC1D3E | 0.463 |
| ORC1 | 0.461 |
| CMYA5 | 0.46 |
| VASN | 0.46 |
| PSMC1 | 0.459 |
| POLR2D | 0.459 |
| EXOSC5 | 0.459 |
| RRN3 | 0.457 |
| SUPT5H | 0.457 |
| NUP153 | 0.456 |
| CHAF1A | 0.454 |
| CDC45 | 0.454 |
| HIST1H2BE | 0.454 |
| PSMB2 | 0.454 |
| NUP85 | 0.453 |
| HIVEP3 | 0.453 |
| PRPF8 | 0.452 |
| CDC73 | 0.452 |
| COPB1 | 0.452 |
| KCTD17 | 0.451 |
| HIST2H2BF | 0.45 |
| RUVBL2 | 0.45 |
| SYT9 | 0.449 |
| SEL1L | 0.448 |
| NAPA | 0.448 |
| DISP2 | 0.447 |
| TRIM52 | 0.447 |
| TBC1D3 | 0.446 |
| PSMD3 | 0.446 |
| MYT1L | 0.445 |
| FAM160A1 | 0.445 |
| AKIRIN2 | 0.445 |
| CTR9 | 0.445 |
| CBWD6 | 0.444 |
| PLEKHA4 | 0.443 |
| RPS14 | 0.443 |
| VPS54 | 0.44 |
| RPS12 | 0.44 |
| ACSF2 | 0.439 |
| TICRR | 0.437 |
| ARCN1 | 0.437 |
| TSG101 | 0.437 |
| KIF3C | 0.436 |
| NUFIP2 | 0.436 |
| AAMP | 0.436 |
| TFIP11 | 0.435 |
| MT1E | 0.435 |
| POLA1 | 0.435 |
| PSMD6 | 0.434 |
| PLA2G4F | 0.433 |
| GOLGA6A | 0.432 |
| TRAIP | 0.432 |
| IGFN1 | 0.431 |
| SUPT6H | 0.431 |
| SAP30BP | 0.431 |
| C2orf27B | 0.43 |
| CLN6 | 0.43 |
| ZNF830 | 0.43 |
| SF3A3 | 0.429 |
| PSMA6 | 0.429 |
| SLC4A1 | 0.429 |
| SNIP1 | 0.429 |
| PSMD1 | 0.428 |
| CSNK1A1 | 0.427 |
| EIF4A3 | 0.427 |
| PSMC2 | 0.425 |
| NUP62 | 0.425 |
| ZFAND5 | 0.424 |
| C3 | 0.424 |
| CWC22 | 0.423 |
| WDR87 | 0.422 |
| SF3A1 | 0.422 |
| CCDC64B | 0.421 |
| NARFL | 0.421 |
| MSH5 | 0.421 |
| GOSR2 | 0.42 |
| LRR1 | 0.42 |
| COPE | 0.42 |
| MFSD12 | 0.42 |
| AHCTF1 | 0.419 |
| SLC5A5 | 0.418 |
| MYO1H | 0.418 |
| RPS19BP1 | 0.418 |
| PAN3 | 0.417 |
| SULT2B1 | 0.416 |
| ATXN1 | 0.414 |
| MED12 | 0.414 |
| POLD1 | 0.414 |
| ATP13A1 | 0.414 |
| CDC6 | 0.413 |
| PWP2 | 0.413 |
| TP53TG3B | 0.412 |
| CDCA3 | 0.412 |
| PSMB1 | 0.412 |
| SNRNP70 | 0.411 |
| LAD1 | 0.411 |
| TP53TG3C | 0.411 |
| TP53TG3 | 0.411 |
| RAD21 | 0.41 |
| HMGCR | 0.408 |
| AQR | 0.408 |
| DDT | 0.408 |
| CTAGE4 | 0.408 |
| GOLGA8O | 0.408 |
| PSMD2 | 0.408 |
| RPS10 | 0.407 |
| ZNF655 | 0.407 |
| DHX38 | 0.406 |
| EXD1 | 0.406 |
| RANBP2 | 0.406 |
| OGFR | 0.406 |
| DNTTIP2 | 0.405 |
| RRP7A | 0.404 |
| PLK1 | 0.404 |
| FAM25B | 0.404 |
| RILPL1 | 0.403 |
| NUP54 | 0.403 |
| APRT | 0.402 |
| CACTIN | 0.402 |
| NBPF10 | 0.402 |
| DYNC1I2 | 0.402 |
| TWISTNB | 0.401 |
| PAF1 | 0.401 |
| RBM39 | 0.401 |
| DDX23 | 0.401 |
| TIMELESS | 0.401 |
| NDC80 | 0.401 |
| PSAP | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 734/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 28/28 |
| blood | 28/28 |
| bone | 26/26 |
| breast | 33/33 |
| central nervous system | 56/56 |
| cervix | 4/4 |
| colorectal | 17/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 16/16 |
| kidney | 21/21 |
| liver | 20/20 |
| lung | 73/75 |
| lymphocyte | 16/16 |
| ovary | 26/26 |
| pancreas | 24/24 |
| peripheral nervous system | 16/16 |
| plasma cell | 15/15 |
| prostate | 1/1 |
| skin | 23/24 |
| soft tissue | 8/9 |
| thyroid | 2/2 |
| upper aerodigestive | 22/22 |
| urinary tract | 28/29 |
| uterus | 5/5 |
Essentiality in NALM6
- Essentiality Rank: 493
- Expression level (log2 read counts): 6.3
Expression Distribution
SEC13 Expression in NALM6 Cells: 6.3